| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002069965A1 Benzimidazole derivatives as therapeutic agents |
| 09/12/2002 | WO2002069906A2 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2002022132A3 Novel topical oestroprogestational compositions with systemic effect |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2001089558A3 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | US20020129398 Transfection, storage and transfer of male germ cells for generation of trangenic species |
| 09/12/2002 | US20020128314 Suppository comprising: a prostaglandin vasodilator; 15-hydroxyprostaglandindehydrogenase inhibitor: and a base material that is solid at room temperature and releases the components when inserted in the urethra, |
| 09/12/2002 | US20020128313 Administering to the herd native or extended semen with a simultaneous or sequential administration of prostaglandin |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128279 Potassium channel blocking agents |
| 09/12/2002 | US20020128276 Administering an estrogen agonist/ antagonist; lowering vaginal pH; treating an urinary tract infection; treating vaginal dryness, itching, undesired spasms, and vaginitis; treating undesired urinary frequency or incontinence |
| 09/12/2002 | US20020128240 Treatment of hyperproliferative diseases using active vitamin D analogues |
| 09/12/2002 | US20020128176 Treatment of erectile dysfunctions with C-Type natriuretic polypeptide (CNP) as a monotherapy or in combination with phosphodiesterase inhibitors |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127558 Genetic polymorphism of MxA protein and use thereof |
| 09/12/2002 | DE10107261A1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 09/12/2002 | CA2445308A1 Progestin co-micronized with a surfactant, pharmaceutical composition comprising same, methods for making same and uses thereof |
| 09/12/2002 | CA2442260A1 Use of one or more shogaol(s) as an aphrodisiac |
| 09/12/2002 | CA2440642A1 Dimeric isoflavones |
| 09/12/2002 | CA2440161A1 Inhibitor of monoamine uptake |
| 09/12/2002 | CA2440141A1 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | CA2440038A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439939A1 Novel aminodicarboxylic acid derivatives |
| 09/12/2002 | CA2439854A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | CA2439779A1 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | CA2439687A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | CA2439647A1 Side-chain-halogenated aminodicarboxylic acid derivatives as medicaments for treatment of cardiovascular disorders |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2438815A1 Novel 2,5-diazabicyclo[2.2.1]heptane derivatives |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1237904A2 14,15-beta-methylene substituted androgens |
| 09/11/2002 | EP1237903A1 11-beta-phenylestradiene derivatives with fluoroalkyl groups in the aromatic side chain, production thereof and pharmaceutical compositions containing these compounds |
| 09/11/2002 | EP1237902A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
| 09/11/2002 | EP1237880A2 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP1237577A2 Transmucosal composition containing a phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 09/11/2002 | EP1237565A1 Betaglycan as an inhibin receptor and uses thereof |
| 09/11/2002 | EP1237555A2 Implant composition containing melengestrol acetate and trenbolone acetate |
| 09/11/2002 | EP1237548A1 Il-8 receptor antagonists |
| 09/11/2002 | EP1237537A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 09/11/2002 | EP0904089B1 Sterilization of female mammals |
| 09/11/2002 | EP0871467B1 Formulation for peptide release |
| 09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/11/2002 | EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 09/11/2002 | CN1368977A Unsaturated cholestane derivatives and their use for preparation of meiosis regulating medicaments |
| 09/11/2002 | CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor |
| 09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
| 09/11/2002 | CN1368879A Use of (-)(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/11/2002 | CN1368853A Prophylactic dietary supplement based on milk |
| 09/11/2002 | CN1368376A Medicine for treating mastoplasia |
| 09/11/2002 | CN1368371A Composite Chinese medicine for gynopathy |
| 09/11/2002 | CN1368370A Composite Chinese medicine applied via rectum and vagina musosa for gynopathy |
| 09/11/2002 | CN1368356A Nano medicine 'Tianjingbushen' and its preparing process |
| 09/11/2002 | CN1368355A Nano medicine 'Suojing' and its preparing process |
| 09/11/2002 | CN1368347A Nano medicine 'Jinjie' and its preparing process |
| 09/11/2002 | CN1368344A Nano medicine 'Kangfuling' and its preparing process |
| 09/11/2002 | CN1368336A Nano medicine 'Tongjingning' and its preparing process |
| 09/11/2002 | CN1368325A Nano medicine 'Zhimiling' and its preparing process |
| 09/11/2002 | CN1368319A Nano medicine 'Shengli' and its preparing process |
| 09/11/2002 | CN1368280A Nano medicine 'Zhuangyao Jiansheng' and its preparing process |
| 09/11/2002 | CN1368271A Nano medicine 'Rulu' and its preparing process |
| 09/11/2002 | CN1368255A Nano medicine 'Baji Bushen' and its preparing process |
| 09/11/2002 | CN1368254A Nano medicine 'Baji' and its preparing process |
| 09/11/2002 | CN1368253A Nano medicine 'Baotai' and its preparing process |
| 09/11/2002 | CN1368246A Nano medicine 'Fukang' and its preparing process |
| 09/11/2002 | CN1368245A Nano medicine 'Gynecologic Baifeng' and its preparing process |
| 09/11/2002 | CN1368244A Nano universal gynecologic medicine and its preparing process |
| 09/11/2002 | CN1368242A Nano medicine 'Fuyankang' and its preparing process |
| 09/11/2002 | CN1368241A Nano medicine 'Tiaojing Zhongzi' and its preparing process |
| 09/11/2002 | CN1368240A Nano emdicine 'Buxue Tiaojing' and its preparing process |
| 09/11/2002 | CN1368236A Nano medicine 'Bushenyijing' and its preparing process |
| 09/11/2002 | CN1368231A Nano medicine 'Shenrongsanshen' and its preparing process |
| 09/11/2002 | CN1368230A Nano medicine 'Canegongbu' and its preparing process |
| 09/11/2002 | CN1368223A Nano medicine 'Danggui Yixue' and its preparing process |
| 09/11/2002 | CN1368222A Nano medicine 'Tiaojing Buxue' and its preparing process |
| 09/11/2002 | CN1368221A Nano medicine 'Tiaojingzhitong' and its preparing process |
| 09/11/2002 | CN1368213A Nano medicine 'Desheng' and its preparing process |
| 09/11/2002 | CN1368201A Nano medicine 'Fukangbao' and its preparing process |
| 09/11/2002 | CN1368195A Nano medicine 'Buxuedanggui' and its preparing process |
| 09/11/2002 | CN1368193A Nano medicine 'Suoyanggujing' and its preparing process |
| 09/11/2002 | CN1368192A Nano medicine for treating menalgia and its preparing process |
| 09/11/2002 | CN1368162A Nano medicine 'Jingangteng' and its preparing process |